About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Outcomes of Screening Mammography for Age, Breast Density, Hormone Therapy Examined By Study

by Rukmani Krishna on March 19, 2013 at 11:52 PM
 Outcomes of Screening Mammography for Age, Breast Density, Hormone Therapy Examined By Study

According to a report, a study that compared the benefits and harms of the frequency of screening mammography to age, breast density and postmenopausal use of hormone therapy (HT) suggests that woman ages 50 to 74 years who undergo biennial screenings have a similar risk of advanced-stage disease and a lower cumulative risk of false-positive results than those who get mammograms annually. The report was published Online First by JAMA Internal Medicine, a JAMA Network publication.

In 2009, the U.S. Preventive Services Task Force issues guidelines that biennial mammography, rather than the previously recommended mammography every one to two years, be performed for women ages 50 to 74, but the updated guidelines did not consider the influence of breast cancer risk factors beyond age, according to the study background.

Advertisement

Karla Kerlikowske, M.D., of the University of California, San Francisco, and colleagues sought to determine whether the benefits, such as early detection, and the harms, such as a false-positive mammography result or biopsy recommendation, differ among women undergoing screening mammography according to age, breast density and postmenopausal HT use.

Researchers analyzed data collected from January 1994 to December 2008 from mammography facilities in community practice that participate in the Breast Cancer Surveillance Consortium (BCSC) mammography registries. Data were collected from 11,474 women with breast cancer and 922,624 without breast cancer.
Advertisement

The authors found that biennial vs. annual mammography for women ages 50 to 74 was not associated with an increased risk of advanced-stage or large-size tumors regardless of a women's breast density or HT use. However, the results indicate that among women ages 40 to 49 years with extremely dense breasts, biennial mammography vs. annual was associated with an increased risk of advanced-stage cancer (odds ratio [OR], 1.89) and large tumors (OR, 2.39).

Study results also show that the cumulative probability of a false-positive mammography result was high among women undergoing annual mammography with extremely dense breasts who were either ages 40 to 49 years (65.5 percent) or used estrogen plus progestogen (65.8 percent) and was lower among women ages 50 to 74 years who underwent biennial or triennial mammography with scattered fibroglandular densities or fatty breasts.

"In conclusion, women aged 50 to 74 years, regardless of breast density or HT use, can undergo biennial rather than annual mammography because biennial screening does not increase the risk of presenting with advanced disease but does substantially reduce the cumulative risk of a false-positive mammography result and biopsy recommendation. Women aged 40 to 49 years with extremely dense breasts who choose to undergo mammography should consider annual screening to decrease the risk of advanced-stage disease but should be informed that annual screening leads to a high cumulative probability of a false-positive mammography result because of the additional screening examinations," the study concludes.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Women Health News

Placenta Unravels Anonymous Miscarriages & Stillbirths
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Predictive Tools for Pregnancy Complications Related to Fetal Growth
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
Urine Ovulation Test may Raise your Chances of Pregnancy
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
Premature Ovary Removal Linked to Accelerated Aging
Oophorectomy's adverse effects raise questions about risk-benefit balance, especially for average ovarian cancer risk women.
Stem Cells Offer Hope for PCOS Root Causes
This study highlights the ovarian resilience achieved through stem cell treatments, providing hope for women struggling with fertility problems related to PCOS.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Outcomes of Screening Mammography for Age, Breast Density, Hormone Therapy Examined By Study Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests